Certified Juvelook clinic · International Juvelook trainer
Explore doctor-led Juvelook scalp treatment at London Finsbury Clinic, a certified Juvelook clinic in King’s Cross with international-trainer experience. We start with the cause of thinning and explain whether a scalp-supporting approach is appropriate for you.
The manufacturer includes hair restoration in its cellular research explanation. We discuss the emerging evidence clearly, alongside established options, with genuine product, an agreed treatment amount and personal aftercare.
Certified clinic · View trainer documentation →From £749 · scalp treatment
Your skin. Your priorities. A thoughtful plan.
Hair thinning is a symptom with more than one possible cause. We assess the pattern, scalp health, timing and medical background before discussing a cosmetic scalp treatment.
The aim is an informed plan for your scalp and hair concerns. Juvelook is an emerging supporting approach; it is not a guaranteed regrowth treatment or a replacement for established care.
Our certified clinic combines international Juvelook trainer experience, repeated visits to South Korea and careful doctor-led assessment. We explain the product, amount and technique selected for you, with time to ask questions.
Suitable preparation, numbing, attentive treatment, aftercare and skincare advice are included. Your doctor reviews the response before recommending more.
Clinic review totals checked 3 November 2026. Explore our patient reviews · Read our selected Trustpilot reviews
Clear treatment choices · complete prices
NCTF 135 HA is included at no additional cost where appropriate. When clinically indicated, a complimentary relaxer treatment may also be included to help reduce oiliness and sebum production and improve the appearance of pores and skin texture. For suitable patients, this may also help reduce redness and support acne control as part of your personalised treatment plan.
These additional treatments are not included in the under-eye protocol.
Our published scalp appointment is £749. Your doctor confirms whether treatment is appropriate, the agreed coverage and prepared amount before you decide. Suitable numbing, agreed administration and aftercare are included. Additional investigations or procedures are explained separately.
Inside your treatment
A Korean injectable combining biodegradable PDLLA particles with non-crosslinked hyaluronic acid, selected for gradual skin-quality care.
Prepared syringe volume depends on preparation. Your doctor explains the agreed amount and concentration. Lenisna / Juvelook Volume is a separate formulation for a different treatment purpose.
Understand your treatment
Patterned hair loss, increased shedding and localised patches can have different causes. We review family history, recent illness, stress, hormonal changes, medicines and previous treatment.
Scalp redness, scale, pain or signs of scarring can change the priority. Your doctor explains whether examination, investigation or specialist care should come before an injectable.
Juvelook combines PDLLA with a non-crosslinked HA carrier. Its potential scalp role concerns the environment around follicles rather than transplanting new hair or directly correcting every driver of loss.
We explain the formulation, original active product and prepared volume. A larger syringe volume alone is not evidence of a stronger or more effective treatment.
VAIM includes hair-follicle stem cells in its proposed cellular mechanism, alongside collagen, vascular and supporting-tissue pathways. These are research topics, not a promise of uniform clinical regeneration.
Our mechanism guide separates manufacturer diagrams, material data and treatment decisions. Your diagnosis and existing care determine whether this emerging approach is relevant.
A PDLLA study investigated macrophage signalling and hair-follicle stem-cell activity in laboratory work and middle-aged mice. It reported changes in follicle measures and hair growth in that model.
This preclinical finding does not establish how reliably Juvelook regrows hair in people, an optimal human course or equivalence to established treatments. Read the primary research abstract ↗
Your doctor discusses suitable established medical options and referral when relevant. A supporting scalp procedure should fit the diagnosis and avoid delaying appropriate treatment.
We agree what change would be meaningful and how to assess it. Photographs under consistent lighting can be useful, while the limits of the evidence remain part of the decision.
The listed scalp appointment is a starting option, not a compulsory package. Timing and further care are planned personally rather than copied from facial treatment or animal research.
We discuss the complete cost, aftercare and review. If treatment is unsuitable or the change is not worthwhile, a different plan or stopping may be the better decision.
Assess the right outcome
Facial and under-eye before-and-after photographs do not demonstrate hair regrowth. We do not use them as scalp results. Your doctor discusses the available evidence and whether photographs or follow-up would help assess your own plan.
Before. During. After.
Bring details of earlier fillers, devices, surgery, medicines and allergies. We assess your skin and explain suitability, the proposed technique and complete price.
We allow suitable numbing time, prepare the skin and check your comfort throughout. You can ask for a pause or further explanation.
You receive personal advice for skincare, activity and contacting the clinic. We plan review around the treatment and your response.
Temporary redness, swelling, tenderness or bruising can occur. Delayed lumps, infection and rare serious injection complications are discussed during consultation, together with area-specific precautions and when to seek help.
Doctor-led treatment in King’s Cross
Founder of London Finsbury Clinic and an international Juvelook and Lenisna (Juvelook Volume) trainer, Dr. Eroglu combines Korean collagen-stimulation protocols with a personal, doctor-led approach.
Your consultation starts by listening to what you would like to improve. We assess skin quality, the under-eye area, pigmentation and facial support before recommending a preparation or combination. Dr. Eroglu also has four years of advanced CPD teaching experience, training other practitioners in anatomy, techniques and treatment planning. Your doctor explains the ingredients, amount, suitability and proposed course before you decide.
We welcome local and international patients, with treatment and review planned around your needs. Our aim is a refreshed appearance that respects your natural features.
The displayed certificate was issued when Beauty Europe / B2 Europe was the UK distribution and training partner. It documents the training completed during that period; distribution arrangements have since changed.
PDLLA + HA · from particles to skin quality
VAIM describes a sequence involving mechanical signalling through Piezo1 channels, calcium entry, a shift towards M2-type macrophage activity and signals to neighbouring cells. Its diagram connects these pathways with fibroblasts, vascular cells, fat-cell precursors and hair-follicle stem cells.
Read the official manufacturer mechanism and benefits explanation ↗
Inside the formulation
The manufacturer describes a porous internal network created through its particle-manufacturing process. It is designed to support cell interaction and degradation through hydrolysis. PDLLA and PLLA share a lactic-acid polymer family but have different material structures and behaviour.
Biodegradable describes the material breaking down over time; it is not a promise that the tissue response disappears on an exact date.
Standard Juvelook contains 42.5mg PDLLA and 7.5mg non-crosslinked HA in an original 50mg vial. Prepared millilitres depend on reconstitution. Your doctor explains the amount and preparation selected for the agreed area.
Lenisna / Juvelook Volume is a separate formulation. Its larger original content and different particle profile are used for a different treatment purpose.
Manufacturer particle technology ↗ · Compare Lenisna / Juvelook Volume →
Material science, explained simply
Glass transition temperature (Tg) describes a polymer changing from a rigid state towards a more flexible state. The manufacturer reports the following material data:
| Condition | Juvelook PDLLA | PLLA comparator |
|---|---|---|
| Dry material | 50–60°C | 60–65°C |
| After hydration | 39°C | 60–65°C |
Hydration changes the material’s flexibility. The manufacturer also discusses clinician-led use of energy-based treatment for softening and dispersing some particle collections. This is a material-management explanation, not a home treatment instruction.
PDLLA is not dissolved by hyaluronidase in the same way as an HA filler. Any lump or unusual change needs clinical assessment; no method is suitable for every situation.
In our clinic’s experience, a coordinated plan can address more than one layer or concern. Juvelook targets skin quality; selected Ultraformer MPT treatment has a separate ultrasound role. A peel may target suitable superficial pigmentation.
The 39°C material data alone does not prove that heating produces greater collagen gains. We choose the device, area, timing and settings for a defined clinical purpose rather than promising universal “activation”.
See our under-eye combination choices → · Explore Ultraformer MPT →
Different questions · different evidence
Human studies explore skin quality, lower-eyelid rejuvenation and selected acne-scar protocols. Product preparation, techniques and schedules vary, so one study cannot predict every clinic combination.
Manufacturer explanations include collagen and elastin pathways, basement-membrane support, blood-vessel formation and adipogenesis. These biological findings do not mean every patient gains every effect.
PDLLA research explores macrophage and follicle signalling, including aged-animal experiments. This is emerging evidence rather than proof of reliable human hair regrowth. A diagnosis remains the first step.
The product page also discusses pigmentation and stretch marks alongside skin rejuvenation, tear-trough care, fine lines and acne scars. These involve different tissue concerns and evidence; they are not automatically covered by one appointment or a promise that every mark will respond. We assess pigment, scar type and the intended treatment area before recommending care.
Read our focused Juvelook hair-loss and scalp assessment guide →
Included care · clear agreement
Your listed appointment includes doctor assessment, suitable numbing, agreed treatment administration, personal aftercare and skincare advice. The product, prepared amount, treatment area and any included combination are explained before treatment.
Additional areas, products or procedures are separately agreed and priced. You can review your response before deciding on further paid care; there is no compulsory package.
Your questions, clearly answered
The listed scalp appointment is £749. Your doctor confirms suitability, the agreed area, product amount and full plan before treatment. Consultation is free.
The manufacturer discusses hair restoration and PDLLA has emerging laboratory and animal research. This does not establish reliable regrowth in people or replace a diagnosis.
Standard Juvelook contains PDLLA and non-crosslinked hyaluronic acid. The original vial is 50mg: 42.5mg PDLLA plus 7.5mg HA.
We review the pattern, duration and pace of shedding, scalp symptoms, medicines, health changes, previous care and your goals. Examination guides whether investigations or referral are needed.
Yes. Patterned thinning and shedding can occur for different reasons. Your doctor explains the likely cause and relevant options rather than assuming one injectable suits everyone.
Sudden or patchy loss, inflammation, soreness or suspected scarring needs diagnosis and appropriate care. A cosmetic scalp injection may not be the right first step.
Emerging research explores the scalp-supporting environment and cell signals involving macrophages and follicle-related cells. These mechanisms remain distinct from demonstrated clinical regrowth.
There is no compulsory package. The proposed starting plan, review interval and any further cost are discussed individually. We do not borrow a facial or animal-study schedule as a proven hair-loss course.
No. Established medical or surgical options may be more appropriate depending on the diagnosis. Your doctor explains where scalp support fits, if at all.
No. We do not present facial or under-eye photographs as hair-restoration results. Outcomes vary and human evidence for PDLLA hair restoration is still emerging.
Assessment, suitable numbing, agreed treatment administration, aftercare and skincare/scalp-care advice are included in the listed appointment. Additional procedures are priced and agreed separately.
London Finsbury Clinic is at 104 Judd Street, King’s Cross, London WC1H 8BU.
Start with a conversation
Meet your doctor to understand your skin concerns and compare suitable Juvelook options and combinations, without pressure to choose treatment.
104 Judd Street, King’s Cross, London WC1H 8BU. A short walk from King’s Cross and St Pancras International.
Explore your treatment area
Manufacturer information · primary research
Official Juvelook benefits and cellular mechanism ↗
Primary PDLLA hair-follicle stem-cell research ↗
The study includes laboratory and animal work. It does not establish an optimal human injection course or guaranteed regrowth.
Related product guides
Read about PDLLA, the HA carrier, particle design and the distinction between a proposed biological pathway and a clinical result.
Our main Juvelook page connects area-specific information with complete prices and the relevant booking options.
Google
Doctify
